WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007002361) 3-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/002361    International Application No.:    PCT/US2006/024426
Publication Date: 04.01.2007 International Filing Date: 21.06.2006
IPC:
C07D 211/38 (2006.01), C07D 211/06 (2006.01), A61K 31/445 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 (US) (For All Designated States Except US).
BARROW, James, C. [US/US]; (US) (For US Only).
LINDSLEY, Craig, W. [US/US]; (US) (For US Only).
SHIPE, William, D. [US/US]; (US) (For US Only).
YANG, Zhiqiang [CN/US]; (US) (For US Only)
Inventors: BARROW, James, C.; (US).
LINDSLEY, Craig, W.; (US).
SHIPE, William, D.; (US).
YANG, Zhiqiang; (US)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 (US)
Priority Data:
60/693,504 23.06.2005 US
Title (EN) 3-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS
(FR) ANTAGONISTES DU CANAL CALCIQUE DE TYPE T 3-FLUORO-PIPERIDINE
Abstract: front page image
(EN) The present invention is directed to 3-fluoro-piperidine compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
(FR)Ces composés 3-fluoro-pipéridine sont des antagonistes des canaux calciques de type T et servent au traitement ou à la prévention de troubles neurologiques ou psychiatriques en rapport avec des canaux calciques de type T. des compositions pharmaceutiques comprennent ces composés et on les utilise pour prévenir ou traiter de telles maladies.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)